Xilinx Inaugurates Expanded Site in Hyderabad for R&D, Technical Support
Xilinx India team pivotal to development, delivery & support of company's flagship programmable platforms
HYDERABAD, India, Mar. 20, 2012 -- Xilinx, Inc. (NASDAQ: XLNX) today underscored its commitment to the emerging, high-growth market and its growing employee base in India with the inauguration of a new, expanded Xilinx India site in Hi-Tech city. The 131,000 square-foot office building is more than double the size of the previous site to accommodate engineering labs and collaboration space for end-to-end product development, a larger, energy-efficient data center, and expanded facilities for customer and employee events.
Hosted by Xilinx President and CEO, Moshe Gavrielov, Senior Vice President of Programmable Platforms Development, Victor Peng, and Xilinx India Site Director and CTO, Vamsi Boppana, the inaugural event began with a traditional lamplighting ceremony to mark the beginning of an exciting new chapter for Xilinx India.
The Xilinx India site, which represents the largest R&D centre outside of the company's U.S. headquarters, is a critical contributor to Xilinx's success as the world's leading provider of 'all programmable' technologies and devices. This includes its newest, industry leading portfolio of 28nm 7 series and Zynq™-7000 Extensible Processing Platform (EPP) families, which enable breakthroughs in price/performance/watt and programmable systems integration.
Currently, more than 400 employees in Hyderabad report into Xilinx's Programmable Platforms Development (PPD) and Worldwide Technical Support groups, which are global organizations responsible for development and delivery of the company's flagship programmable platforms and support of local, regional and multi-national customers in India. The expansion and increasing role of the Xilinx India engineering team is well aligned to the National Policy on Electronics goals to transform India into a global R&D hub.
"We're proud to commemorate the opening of our new Hyderabad site today and to celebrate the incredible contributions of our employees in India," said Gavrielov at today's inauguration ceremonies. "The Xilinx India engineering team will continue to play a pivotal role in our success as part of Xilinx's world-class PPD engineering organization. Notably, more than half the Zynq engineering team is based in India, with some aspects entirely designed and verified in India. The India team has sole ownership and development responsibility for significant aspects of our next-generationtool suite accelerating programmable design productivity."
About Xilinx
Xilinx is the world's leading provider of programmable platforms. For more information, visit: http://www.xilinx.com/.
|
Xilinx, Inc. Hot IP
Related News
- Xilinx Underscores Commitment to Growth in China at Grand Opening of Expanded Beijing Site, New R&D Center
- BBC R&D Designs Xilinx FPGAs into New Camera-Back Mount to Support Transmission of Video Over IP
- Synthara targets breakthrough edge-AI chips with support from a global coalition of investors and R&D partners
- PLDA Announces Augmented Presence in Asia with Increased R&D, Support and Sales, and a New Chinese Language Website
- Cadence Opens Expanded Shanghai Sales Office and R&D Center
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- SiFive and Kinara Partner to Offer Bare Metal Access to RISC-V Vector Processors
- Imagination Announces E-Series: A New Era of On-Device AI and Graphics
- Siemens to accelerate customer time to market with advanced silicon IP through new Alphawave Semi partnership
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |